Barriers to their training and retention threaten medical research
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gill, G. N. Am. Scholar 53, 353–368 (1984).
Kwan, J. M. & Gross, C. P. JAMA Netw. Open 6, e2332982 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
In the past 2 years, S.O.R. has provided consultancy services to Pfizer, AstraZeneca, Northsea Therapeutics, Third Rock Ventures and Medicxi and received research support from GSK.
Rights and permissions
About this article
Cite this article
O’Rahilly, S. Academic clinician–scientists risk becoming an endangered species. Nat Med 29, 2989 (2023). https://doi.org/10.1038/s41591-023-02626-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02626-8
This article is cited by
-
French pediatric nephrologists are in crisis: the consequences of paradoxical injunctions and a plea for action
Pediatric Nephrology (2024)